Syringe-Injectable Antibodies Poised to Decentralize Healthcare Delivery

Current antibody treatments for critical diseases necessitate intravenous administration, requiring patients to visit hospitals for lengthy infusions and placing significant demands on specialized healthcare infrastructure and personnel. This model centralizes care and limits accessibility.

Researchers at MIT, led by Professor Patrick Doyle and graduate student Talia Zheng, have achieved a major 

Sector: Electronic Labour | Confidence: 90%
Source: https://www.technologyreview.com/2026/02/24/1132086/reformulated-antibodies-could-be-injected-for-easier-treatment/

#FIRE #Circle #ai